Autophagy and Lipid Metabolism – A Cellular Platform where Molecular and Metabolic Pathways Converge to Explain Dengue Viral Infection by Orozco-García, Elizabeth & Gallego-Gómez, Juan Carlos
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 6
Autophagy and Lipid Metabolism – A Cellular Platform
where Molecular and Metabolic Pathways Converge to
Explain Dengue Viral Infection
Elizabeth Orozco-García and Juan Carlos Gallego-Gómez
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/61305
Abstract
Dengue virus (DENV) is one of the most prevalent human pathogens worldwide. It caus‐
es a huge socioeconomic burden with approximately 400 million infections per year, but
yet there is no vaccine or antiviral that is currently effective against the disease. DENV is
spread by the mosquitoes Aedes aegypti and Aedes albopictus, and viral replication within
the mosquito vector is required for transmission to human host. During its replication cy‐
cle, the virus cause significant changes to the host transcriptome profile, especially in the
metabolic and trafficking pathways. Recent studies have shown a strong association be‐
tween autophagy and lipid metabolism modulation.
For many years, biochemistry studies have been forgotten and replaced by the most ad‐
vanced techniques and theories in molecular biology and their promises for solving the
"life code"; however, after many years of strong molecular biology research, it had not
found the key of many problems with which we have the elemental biosystems like vi‐
ruses. Decades of molecular virology investigations did not give more light about several
cellular processes that occurred into the host cells when the infections happen. The mo‐
lecular virologists have cloned many viral genes, manipulating full viral genomes, and
engineering chimeric constructs to study many details at the molecular level, but the host
cell and the encrypted viruses do not want to reveal their secrets.
Only with the new perspective of complex diseases, a new approach has emerged: An in‐
tegrative methodology wherein molecular cell biology is converging with the most pure
and elegant biochemistry. In this way, more extensive research is necessary for future
comparative analyses of the host and vector metabolic/signaling environments required
for viral replication.
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1. Introduction
1.1. Dengue Virus (DENV): Some clinic and basic issues
Emergent viruses with major impact in human health include several agents of Flavivirus
gender, Flaviviridae family, the most important of these are DENV (Dengue Virus), YFV
(Yellow Fever Virus), JEV (Japanese Encephalitis Virus) and WNV (West Nile Virus) [1]. There
are nearly 3.6 billion people at risk of infection with DENV in tropical and subtropical countries
[2]. In more than 100 endemic countries with an estimated nearly 390 million of DENV
infections per year, approximately 100 million of dengue fever cases are estimated annually
with over 2 millions cases of potentially fatal dengue hemorrhagic fever [3, 4]. In most cases,
the symptoms of DF that include an acute febrile illness with retro-orbital pain, myalgia,
arthralgia are self-limited [5]. However, in a proportion of people, the disease progresses to
the severe clinical manifestations classified as dengue shock syndrome (DSS), which are
characterized by the plasma leakage leading to hypovolemic shock and/or dengue hemorrha‐
gic fever (DHF), which are characterized by massive bleeding, thrombocytopenia, evidence of
plasma leakage such as pleural effusion and a rise of hematocrit, both of which has a high
mortality rate [6-8].
DENV is a positive-single strand RNA virus surrounded by an icosahedral nucleocapsid (C)
with approximately 10,700 bases, a unique open reading frame that codify to one polyprotein,
which is post-translational cleaved by cellular and viral proteases. The 5’ end contains the
region encoding the structural proteins in the following order: core protein (protein C),
membrane precursor protein (protein M), and envelope protein (protein E). The remainder of
it genome encode for seven non-structural proteins, xlink, NS2A, NS2B, NS3, NS4A, NS4A,
and NS5 [9].
DENV exists as a four serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). All of them have
a same transmission cycle, which include vertebrate hosts (primate and human) and inverte‐
brate vectors, mosquitoes of the following species: Aedes aegypti, A. albopictus y A. polynesien‐
sis mosquitoes. An infection with one serotype provides lifelong protective immunity to that
serotype. But, there is no cross-protective immunity between serotypes [10, 11]. Inside each
one of these serotypes, there are several virus groups named genotypes.
2. Autophagy
This is defined in a general form like a catabolic selective process by means of which cyto‐
plasmic material is transported to lysosomes for their degradation [12]. The autophagy is a
remarkably conserved cellular process, from yeast to human, responsible for removing
damaged organelles and misfolded proteins, and for maintaining cellular homeostasis under
both normal and stress conditions [13-15]. Compartmentalization in eukaryotic systems
brought numerous evolutionary advantages, but also great and new challenges with it, such
as the selective removal of damaged organelles, controlled organelle number and quality, or
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the utilization of their components as potential energy source during times of starvation. In
this way, autophagy represents an evolutionary answer to these challenges. It enables the
recycling of intracellular components and allows cells to survive or death [16] (Figure 1).
Figure 1. Functions of autophagy
The primary role of autophagy is to protect cells under stressful conditions. Under this
viewpoint, both autophagy and the vertebrate immune system play essential roles to maintain
cellular homeostasis in the face of external perturbations [17]. Indeed, several studies have
revealed the narrow relationship between autophagy and the vertebrate immune system [18].
Besides, the crosstalk has become evident between autophagy and apoptosis [19-22] because
the induction of autophagy has often been linked to inhibition of apoptosis [23].
More than 30 genes have been identified as crucial in the autophagy regulation process in
yeast, which are known as ATG (autophagy-related genes). Many of these genes have
homologs in mammals and are grouped according to expression and participation in the
different stages of the autophagic route [12]. The activation of this pathway depends on the
kinase mTOR (mammalian Target of Rapamycin) identified as the main negative regulator
when the cell is in the presence of growth factors and abundance of nutrients. Under starvation,
mTOR activity is inhibited. And consequently, the autophagy is activated allowing the
recruitment of complexes inducers of the route [24, 25]. There are three mechanisms identified
for autophagic degradation: macroautophagy, microautophagy, and chaperone-mediated
autophagy (CMA).
Macroautophagy imply the formation of double membrane vesicles recognized as autopha‐
gosomes. It engulfs cytoplasmic components and then are fused to lysosomes, carrying the
cytosolic material until the lysosomal lumen where a hydrolases, lipases, and cathepsins
degrade it [26, 27]. Therefore, we can divide the pathway into 4 basic steps: initiation, elonga‐
tion, termination, and fusion. During initiation, the recruitment of protein complexes, such as
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phosphatidylinositol-3-kinase Class III (PI3K), Vps15, Vps34, and beclin-1, that are critical to
the autophagosome formation is given [28]. During the elongation, the assembly occurs. In
this stage, the related protein complex ATG5-Atg12-Atg16, the lipid conjugation complex LC3-
II- phosphatidylethanolamine (PE), and the respective conjugating enzymes, which act
similarly to ubiquitin ligase system, link lipid that allows the growth of the double membrane
due to the transformation that undergone LC3-I to LC3-II, which has a PE-binding domain,
the main lipid component of autophagosomes. Later, in the termination stage, the double
membrane vesicle is closed with the intracytoplasmic content therein, which is possible
because the cut that performs Atg-4 enzyme on the binding LC3-II-PE permits the release of
the complex into the cytosol preventing the continuation of joining new lipid molecules [28].
Subsequently, the fusion process occurs between autophagosomes and lysosomes, which
generate a vesicular structure called autophagolysosome or autolysosome. This process is
mediated by the cell membrane fusion proteins, such as integral proteins SNARE (soluble N-
Ethylmaleimide-sensitive factor-attachment protein receptor) [29], the Rab family proteins,
especially Rab7 and Rab9, that are involved in the transport of the vesicles and fusion with
target membranes [30]. And besides, the lysosomal membrane receptor LAMP2 allows the
attachment between vesicular membranes and autophagosome contents discharge into the
lysosome forming the structure known as autophagolysosome, where protein degradation
occurs [31, 32] (Figure 2).
Figure 2. The Process of Macroautophagy. A portion of cytoplasm (including organelles) is enclosed by a phagophore
or isolation membrane to form an autophagosome. The outer membrane of the autophagosome subsequently fuses
with the lysosome, and the internal material is degraded in the autolysosome.
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The second possible mechanism is microautophagy. It involves direct lysosomal membrane
invaginations production to generate vesicles or tubules capturing surrounding cytoplasm.
Microautophagy studies has mainly been developed in yeast, wherein several genes have been
found sharing the macroautophagy and microautophagy pathways, but the components and
regulation systems are still not well understood [33]. For the CMA mechanism, the cargo is
specifically selected by the unique pentapeptide motif present in the amino acid sequence
(KFERQ), which is recognized by the chaperone proteins specially Hsc70, in where the
membrane receptor LAMP2 (Lysosome associated membrane protein 2] carrying the load into
the lysosome lumen for degradation [34].
In the past years, autophagy has emerged as a critical player in the control of viral infection
and immunity [35-39]. On one hand, autophagy can serve as a host defense mechanism for
some pathogens by clearing them out of the cells [40-42]. On the other hand, many positive-
stranded RNA viruses have been reported to subvert this cellular machinery to favor their own
replication and release [23]. This issue will be discussed below.
3. Cellular metabolism in viral infections: Rediscovering the other side of
the coin
Metabolism is broadly defined as the sum of biochemical processes in living organisms that
either produce or consume energy [43]. In the “Golden Age of Biochemistry” (1920s to 1960s),
most of the metabolic network in humans and other organisms, which included routes like
glycolysis (Embden, Meyerhof, and Parnas), respiration (Warburg), the tricarboxylic acid
(TCA) and urea cycles (Krebs), glycogen catabolism (Cori and Cori), oxidative phosphoryla‐
tion (Mitchell), and the supremacy of ATP in energy transfer reactions (Lippmann) was
defined. This research was awarded with about 15 Nobel Prizes in Physiology, Medicine, or
Chemistry. All of them were related to energy balance or core metabolic pathways [43].
Richard W. Hanson wrote "By 1970, the writing was on the wall for metabolism; it  was
largely considered a "mature area", lacking excitement; molecular biology was the area of
the future" [44].
"A sure sign of this was that graduate students in biochemistry almost never selected their thesis research
in metabolism. The course in intermediary metabolism that I taught was dropped from the curriculum
of our graduate education program; our students were expected to learn all they needed to know about
metabolism as undergraduates before they attended graduate school. After all, as a graduate student
once said to me, "the great problems in metabolic research have been solved". As long as diseases like
diabetes, obesity, and atherosclerosis, remain to be cured, there will be no shortage of interest in
metabolism" [44].
In this way, the understanding of diseases in light of alterations in metabolic status was
dropped and shifted by the search of an explanation based on the nascent era of molecular
biology. However, the ongoing exploration of molecular biology and disease complexity has
stimulated a revival of interest in intermediary metabolism [45]. In this view, several works
Autophagy and Lipid Metabolism – A Cellular Platform where Molecular and Metabolic Pathways Converge...
http://dx.doi.org/10.5772/61305
167
propose a new way to arrive the disease: cell metabolism, because it affects cell signaling and
modulate protein trafficking, localization, and enzyme activity [43]. For example, Acetyl-CoA
plays a central role in intermediary metabolism (carbohydrate, fatty acid, and amino acid
oxidation,) and at the same time have tremendous influence on cell signaling and gene
expression [46-48]. Recently, it has been demonstrated that some biomarkers of metabolic
syndrome are related with any infection, acute or chronic in patients [49].
To reach a deep and elegant comprehension of the role of metabolism in all levels of the human
being, it is better to take the exact quotation of DeBerardinis and Thompson: "...the metabolism
pervades every aspect of biology from the single-cell to whole organism level. No cellular
functions occur independently of metabolism, and a metabolic perturbation at one node has
ripple effects that can extend throughout the network and out into other systems. Thus,
metabolic disturbances have an extremely long reach, and this extends to disease pheno‐
types..." [43].
The Warburg effect is a concept used to link metabolism and cancer wherein a disturbance of
cellular metabolic activity is at the root of tumor formation and growth [43]. Thereby, dysre‐
gulated cellular metabolism is a key feature of cancer [50-53]. This concept could be adapted
perfectly to viral infections, because viruses are biological entities that depend on cell metab‐
olism to replicate and spread. Therefore, it would be expected that the success of viruses inside
the cell will be dependent on their ability to subrogate the metabolism and put it in his favor.
It had been shown in this sense that tumor cells display increased metabolic autonomy in
comparison to non-transformed cells [51]. In the case of viral infections, this "metabolic
autonomy" may be triggered by a viral entity in normal cells. Thinking about it, it is not absurd
if we take into account that many genes implicated in several signaling/metabolic pathways
have also been reported to be modulated and altered in viral infections [54-57]. How these
metabolic pathways are regulated in infected cells, including if they fluctuate according to
infection stage or at the cell cycle, remains to be a question. It will be important to determine
whether viral infection can regulate all aspects of the metabolic dynamics or if any special
metabolic pathway implicated in their replication or pathogenicity exists.
Many pathogens have developed sophisticated molecular machinery, which interferes with
host cell signaling. Thereby, effector molecules are introduced or released by the pathogens
during the invasion of the host [55, 58, 59]. Autophagy is a evolutionarily refined and sophis‐
ticated process wherein molecular cell signaling and cellular metabolism regulation converge
to regulate the intermediary metabolism (Figure 3) including the lipid metabolism through a
process called lipophagy, which modulate the degradation of lipid droplets in triglycerides
and free fatty acid that can be used as a fuel to elevate the rate of β-oxidation and consequently
of energy production [60-62], which recently has been demonstrated that some pathogenic
agents can subvert this cell process to ensure their own survival.
Recent investigations using genetic, cell biology, and biochemical approaches have led to a
better understanding of mechanistic interaction between pathogens and hosts. Based on this,
a resource that permit integrate terms of ViralZone, UniProtKB, and GO, has been created,
which provide a global view of viral biology and their complex host interactions, based in
evasive adaptations and inactivation of antiviral effectors [63]. Advancements in research are
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now fueled by increasing interests aimed at the discovery of novel therapeutic interventions
against major infectious diseases [64]. The cell biology of microbial pathogenesis has opened
many doors for future research into the role of lipids in host-pathogen interactions because
lipids of both host and pathogen play critical roles in the pathogen stability to replicate and
persist in host cells, and these interactions are very complex and dynamic [58].
The metabolic host cost and contribution of lipids (biosynthesis, catabolism, and trafficking)
to the formation of replication factories is in the early stages of investigation [65-69], and yet
is need to know pathogen and host lipid profiles as a starting point for tests of functional
relevance and comparative profiling in several physiological conditions (status before/after
infection) to better understand the details of the metabolic role in the different conditions of
the disease and dissect the complicated signaling during host-pathogen interactions for
developing drugs and disease biomarkers pathways identification [64].
4. Role of autophagy in infectious disease
The intracellular invaders, after million years of evolution, have developed several sophisti‐
cated strategies for evading the host defenses like the immune system. In this regard, autoph‐
Figure 3. Autophagy and intermediary metabolism relationship
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agy is a complex cellular process that can have a dual role in viral infections depending on the
pathogenic agent and host [70, 71]. Although it has been extensively cited and reviewed, the
role of autophagy in maintaining the cellular homeostasis [12, 13] still remains to be elucidated
in terms of what is their precise role in viral infection.
Considering several infectious agents, there are a number of important findings. For example,
macrophages can eliminate Legionella pneumophila infection through cholesterol or lipid-raft-
rich induction of autophagy [72]. Mycobacteria usurp the host lipid stores for energy produc‐
tion via β- oxidation of fatty acyls, using the glyoxylate cycle enzymes isocitrate lyases for
survival and persistence in its human host [73, 74]. Helicobacter pylori have been related with
elevated cholesterol levels and metabolic syndrome alterations. However, it remains contro‐
versial [75, 76]. In HSV-1 (Herpes Simplex Virus), the virulence factor ICP34.5 inhibits
autophagy via inhibition of Beclin 1 and PKR [77], and Us3 acts as a viral Akt surrogate to
activate mTORC1 inhibiting host autophagy [78]. Curiously, additional members of the herpes
virus family employ similar strategies to inhibit autophagy. Gamma herpes virus 68 (gHV68)
encodes a virulence factor vbcl2 (M11), which inhibits host autophagy via interaction with
Beclin 1 [79]. Kaposi’s Sarcoma Herpes Viruses (KSHV) interact with ATG3 and inhibit
autophagy [80]. Human Cytomegalovirus (HCMV) inhibits autophagy via upstream activa‐
tion of mTOR signaling [81]. Autophagy functions as an antiviral host defense of central
nervous system against Sindbis Virus (SIN) infection [40, 41].
Hepatitis C virus (HCV) infection has a controversial role in lipid metabolism and autophagy.
It has shown that this infection is associated with enhanced lipogenesis, reduced β-oxidation,
decreased lipoprotein secretion, and increased autophagy counteracting the alterations in lipid
metabolism induced by HCV. In this way, a disruption of autophagic process might contribute
to develop steatosis (occurs in about 50% or more of patients) in patients with HCV [82, 83].
It has also been described that the infection of human cells with Poliovirus and Rhinovirus
induces autophagosome formation, which are used as sites of viral RNA replication [84].
Autophagosome is required for the formation of Coronavirus replication complexes with the
formation of the double membrane vesicles significantly enhancing viral replication efficiency
[85]. The use of small interfering RNAs against LC3 or Atg12 has shown to reduce both the
intracellular and extracellular yields of poliovirus (+ss) [84]. Reduction in the intracellular
concentration of Atg7 reduces the amount of viral capsid protein synthesized in Coxsackievi‐
rus B3 [86]. Hepatitis C Virus (HCV) infection was found to activate autophagy, and it extends
cell survival for the establishment of a successful viral infection [87].
It should be noted that not only RNA virus (poliovirus, etc.) but also DNA virus (Epstein-Barr
virus) infection can induce autophagic machinery, and whether the activation of autophagic
machinery can enhance viral replication (poliovirus and mouse hepatitis virus) or not (Vaccinia
virus and Herpes Simplex Virus type 1 etc.) depends on the type of viruses [84, 85, 88-90] and
on cell type infected [91]. Thus, for some areas for research, the development of the specific
inducers of autophagy will offer a promise as a novel class of antiviral therapeutics [16], while
for others, the design of specific inhibitors of autophagy could provide new therapeutic
strategies [92]. Either will serve as a powerful tool to dissect the autophagic process.
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In summary, many different viruses and other pathogens can induce the cellular process, such
as apoptosis and autophagy, and on the other hand, host cells can also activate the same
pathways when they participate in clearance of infectious agent (Figure 4). Thus, although
some viruses may encode one or more inhibitors of both these processes, others have been
shown to induce autophagosome-like structures and to benefit from their formation, which
may be critical for the viral spread within the infected tissues [35]. Although numerous studies
support the beneficial role of autophagy in +ssRNA virus replication [23], the induction of this
process is not always favorable for them. And drawing the path and explaining this behavior
have shown interesting findings for some researchers.
Figure 4. Viral modulation of autophagy. Several viruses have been shown to block or activate various stages of au‐
tophagy process.
5. DENV infection and autophagy: Molecular and metabolic convergences
DENV is a major but neglected global public health problem, and despite many efforts, they
are made to understand the mechanisms by which it usurps the host cells and this research
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field has grown dramatically during the last years with multiple studies in molecular and
evolutionary biology [93-96], genome sequencing [97-99], construction of infectious clones
[100], and use of these to attempt to dissect the specific role of each viral protein [101, 102], and
immunological approaches [103, 104]. All of these have failed to produce results that allow the
design of vaccines or drugs effective to cure this disease [105-107], and the secrets of DENV
and its pathogenesis remain unclear. However, a recent viewpoint of the disease highlights
the relevance of the relationship between both hosts and vector systems with the viruses and
assign a key role to energy metabolism alterations during the infection, indicating that the
virus reprogram the central carbon metabolism (lipid, glucose, TCA cycle and others)
[108-112] in order to facilitate their own replication.
Understanding how DENV can differently infect mammals and insect cells is a very interesting
issue. In the last years, there has been a notable increase in the research for mosquito DENV
infection, revealing the importance of identifying this dual behavior between the host and
vector in order to know the cell biology of viral infection. In the enveloped positive-sense RNA
viruses such as DENV, a cytoplasmic replication of its are associated with a dramatic rear‐
rangement of host cellular membranes, the merging of viral and target cell membranes, and
endosomal trafficking routes are essential to carry out a successful replication cycle [113], and
these virus-induced changes the result in induction of vesicular structures that envelope the
virus replication complex [114].
A few years ago, it was postulated that autophagosomes might play a structural role in the
replication complex formation, and numerous investigations about the role of autophagy in
DENV infection were conduced. In 2008, a researcher group from the National Cheng
University in Taiwan was the first to demonstrate that DENV can activate autophagic machi‐
nery and induce autophagosome formation to promote viral replication, and ATG5 is directly
implicated in this activation process [6]. Also, it has been demonstrated that DENV2 induce
autophagy and prevent premature cell death, thus, an inhibition of autophagy abolishes its
protective role against cell death providing an unfavorable environment for the viral propa‐
gation leading to a reduced viral replication [115]. There were experiments to compare single-
cycle infections of murine embryonic fibroblasts derived from autophagy-proficient and
autophagy-deficient mice showing clear reductions in the yield of extracellular virus in the
absence of a functional autophagy pathway [6]. But in 2009, it was demonstrated that DENV
replicates on endoplasmic reticulum (ER) cisternae invaginations and not on classical auto‐
phagosomes [116]. From this discovery, scientists kept researching the role of autophagy
induction in DENV infection.
In the same year, it was shown that the DENV Capsid structural protein contained determi‐
nants for lipid droplets targeting. This association was a determinant for reach DENV yield
[117], and this discovery was associated with previous findings that reported liver vacuoliza‐
tion and steatosis in DENV infected mice and fatal human cases of DHF [118-120], suggesting
a possible role for lipid metabolism in DENV pathogenesis. That was when researchers
reported that autophagy process induced by DENV infection plays an indirect role in DENV
replication by the modulation of cellular lipid metabolism. Furthermore, it stimulated a cellular
triglycerides depletion that are stored in the lipid droplets, leading to release free fatty acids,
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increased β-oxidation, and energy production to raise the virus yield [121-125] (Figure 5).
Subsequently, it was shown that autophagy is mediated in a cell type specific manner, given
that autophagy does not have a significant role in DENV replication in monocytic cells [91].
More recent studies in suckling mice demonstrated that DENV infection induce autophagy
mechanism in vivo, and it played an important role in viral replication, clinical symptoms
development, and survival rate [126]. Although it has been widely supported that the autoph‐
agy role in DENV infection is more related to a metabolic requirement, it also has been shown
that the autophagy pathway plays a determinant role in viral maturation [124], which conduce
to think that autophagy does not have a unique function in the viral replication cycle.
Figure 5. Roles for autophagy during DENV infection From [122].
The discovery of vector factors altered during DENV infection of mosquito may help to identify
conserved protein families and pathways that represent both anti-viral mechanisms and
requirements for viral life cycle in the vector, and understanding these effects in mosquito
vector and correlating it with conserved mammal pathways could help to comprehend the
host interactions and development of methods to treat and prevent viral infection and spread.
In this way, the mosquito vector, as well as the cell lines, derived from it, was transformed in
novel and interesting study models. It has been described in mosquito MAL04 and C6/36 cells
that DENV ensures its fusion in late endosomes exploiting cell-controlled differences between
lipid compositions of different organelles through interactions between virus and endosomes
rich in anionic lipids, protecting against premature release, viral inactivation, or endosome
fusion pore opening [127].
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The fat body plays a major role in intermediary metabolism, and it is the central storage depot
of nutrients and energy reserves essential for the holometabolous insects’ life, which must
accumulate at least a minimal amount of nutrients in larval stages to survive during starvation
and metamorphosis. Lipids, mainly triglycerides, represent the major component of fat body
and are the main source of metabolic fuel, it are stored in the core of lipid droplets, which are
mobilized for several purposes as energy provision to flight muscles, ovaries lipids provision
and overall maintenance of metabolic activity [128]. The lipolytic machinery identified in
insects includes two lipases: TGL and Brummer lipase, and two evolutionarily conserved lipid
droplet proteins, Lsd1 and Lsd2 [129]. Current information indicates that insects share with
mammals and other organisms, several aspects of the mechanisms of deposition and mobili‐
zation of triglycerides. This information validates the use of insect models to investigate basic
questions related to the processes of lipid storage and mobilization [130].
DENV drastically alters the lipid profile of mosquito-infected cells, increasing the expres‐
sion of lipids that have the capacity to change the physical properties of the bilayer such
as: bilayer curvature, permeability, and recruitment/assembly of protein complexes in the
membrane. Several of the identified molecules also function as bioactive messengers that
control  signaling  and membrane  trafficking  pathways  in  the  cells  [131].  These  observa‐
tions  shed  light  on  the  emerging  role  of  lipids  in  shaping  the  membrane  and  protein
environments during viral infections and suggest membrane organizing principles that may
influence virus-induced intracellular membrane architecture [131].  Later,  a  transcriptome
study  in  Aedes  aegypti  infected  with  several  flaviviruses  (WNV,  DENV  and  YFV)  was
described and an expression profile was observed with 20 significantly upregulated genes
and 15 downregulated genes quite similar among them. Something of  these genes were
related with the regulation of genic expression (juvenile hormone-inducible protein, core
histone H3),  genes related with antiviral  response were downregulated (Jak-STAT path‐
way downregulated, Toll pathway) and other genes related to ion binding, ion transport,
several metabolic processes and peptidase activity [132].
In [133], a mosquito protein interaction network based on large-scale protein interaction
datasets was developed, and 714 putative dengue-associated mosquito proteins (physical
interaction assays, RNAi and microarray) were identified and predicted. Subsequent analysis
of these proteins highlighted a sub-network, four regions of highly interconnected proteins
with closely related functions (replication/transcription/translation (RTT), immunity, trans‐
port, and metabolism). 15 out of 23 proteins (65.2%) were highly interconnected in metabolism
region. Consequently, the host infected by the virus can experiment dramatic metabolic
alterations. These results support the presence of some common host requirement of DENV
in humans and mosquitoes.
6. Concluding remarks and perspectives
After reviewing the historical issues about biochemistry with emphases on metabolism,
together with the remarkable findings in cell molecular biology of autophagy pathways, it is
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clear that right now, we have a great open field for research. Curiously, the animal viruses,
during several decades, had been studied, but under the viewpoint of virus-host cell interac‐
tions wherein the cell and the viruses have been considered isolated entities. Only in the last
decade where the Cell Biology of Virus Infection emerged [134] was considered the cell as the
structural and functional unit of infection. Therefore, now, the animal viruses play a role in
the physiology of the cell, mimicry and using the metabolic and autophagic cell pathways for
the completion of their viral cycles.
An overview was shown here for understanding the viral disease and other human pathologies
from an integrative perspective including the theoretical framework and methodology of
biochemistry fused to the molecular biology in a cellular compartment (autophagosome),
which is triggered for several injuries and/or diseases.
It is important to establish the differences in mechanisms of infection. Therefore, in the basic
requirements for this process in both vector (mosquito) and host (mammal), it is important to
determine whether it alters in a similar way the metabolism in both models, although the
molecular signaling through which these metabolic changes are induced to be different for
everyone. It is very interesting that all of these recent researches in mosquitoes suggest
alterations in JACK / STAT signaling, toll-like receptors, and metabolism (especially lipid). But
knowing that autophagy is conserved from yeast to mammals, the role of autophagy has not
been reported in DENV infection in mosquitoes. Moreover, there is a recent research which
supports that autophagy is not decisive in the infection in monocytes. It appears that the
autophagy is dependent on the cell type.
Together the ideas exposed here with the remarkable findings of several researchers give us a
whole landscape where it is possible to find some cellular processes or events, which can be
modulated by drugs trying to discover new therapeutical tools.
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